Pola Orbis HoldingsPOLA ORBIS HOLDINGS INC.4927東証プライム化学FY ending Dec 2025, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥9 is left as operating profit. Revenue changed -0.0% from the prior year, operating profit +13.6%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2021 | 6.6% | 0.86× | 5.6% | 1.21× | 6.8% |
| 2022 | 6.9% | 0.80× | 5.5% | 1.21× | 6.7% |
| 2023 | 5.6% | 0.85× | 4.7% | 1.20× | 5.7% |
| 2024 | 5.5% | 0.85× | 4.6% | 1.20× | 5.5% |
| 2025 | 5.6% | 0.86× | 4.8% | 1.21× | 5.7% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 178,642 | 166,307 | 173,304 | 170,359 | 170,285 |
| Cost of revenue | 28,720 | 31,037 | 31,227 | 31,846 | 32,021 |
| Gross profit | 149,921 | 135,270 | 142,076 | 138,513 | 138,264 |
| SG&A | 133,033 | 122,688 | 125,996 | 124,702 | 122,570 |
| Operating income | 16,888 | 12,581 | 16,080 | 13,810 | 15,693 |
| Pretax income | 17,612 | 12,311 | 15,360 | 14,649 | 13,296 |
| Income tax | 5,821 | 804 | 5,627 | 5,341 | 3,823 |
| Net income attributable to owners | 11,734 | 11,446 | 9,665 | 9,286 | 9,472 |
| Operating margin | 9.5% | 7.6% | 9.3% | 8.1% | 9.2% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Dec 2021 | FY ending Dec 2022 | FY ending Dec 2023 | FY ending Dec 2024 | FY ending Dec 2025 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥71.7B | ¥62.6B | ¥46.4B | ¥47.3B | ¥61.9B |
| Total assets | ¥208B | ¥205.9B | ¥201.2B | ¥200.3B | ¥197.9B |
| Net assets | ¥173.3B | ¥171.5B | ¥168.4B | ¥164.9B | ¥163.1B |
| Share capital | ¥10B | ¥10B | ¥10B | ¥10B | ¥10B |
| Trade receivables | ¥17.5B | ¥17.8B | ¥17.8B | ¥17.5B | ¥17.6B |
| Property, plant and equipment | ¥40.4B | ¥44.4B | ¥53.7B | ¥57.5B | ¥56.7B |
| Intangible assets excluding goodwill | ¥15.4B | ¥12.6B | ¥11.9B | ¥11.7B | ¥11.1B |
| Goodwill | ¥2.37B | — | — | — | — |
| Investment securities | ¥12.1B | ¥16.2B | ¥17.4B | ¥15.4B | ¥14.6B |
| Current assets | ¥129.6B | ¥118.3B | ¥107.7B | ¥106.1B | ¥105.2B |
| Current liabilities | ¥25.2B | ¥26B | ¥25.6B | ¥27.4B | ¥26.3B |
| Trade payables | ¥2.51B | ¥2.75B | ¥2.75B | ¥2.26B | ¥2.21B |
| Long-term borrowings | ¥72M | ¥59M | ¥46M | ¥40M | ¥30M |
| Total liabilities | ¥34.8B | ¥34.5B | ¥32.8B | ¥35.4B | ¥34.8B |
| Non-controlling interests | ¥220M | ¥291M | ¥348M | ¥23M | ¥25M |
| Equity attributable to owners of parent | ¥172B | ¥170.9B | ¥169.1B | ¥166.2B | ¥164.2B |
| Retained earnings | ¥83.9B | ¥82.8B | ¥80.9B | ¥78.7B | ¥76.6B |
| Treasury stock | -¥2.87B | -¥2.86B | -¥2.84B | -¥2.92B | -¥2.92B |
EDINET (FSA Japan)
有価証券報告書-第20期(2025/01/01-2025/12/31)
EDINET (FSA Japan)
有価証券報告書-第19期(2024/01/01-2024/12/31)
EDINET (FSA Japan)
有価証券報告書-第18期(2023/01/01-2023/12/31)
EDINET (FSA Japan)
有価証券報告書-第17期(2022/01/01-2022/12/31)
EDINET (FSA Japan)
有価証券報告書-第16期(令和3年1月1日-令和3年12月31日)
EDINET (FSA Japan)
有価証券報告書-第15期(令和2年1月1日-令和2年12月31日)
Extracted from XBRL: 52 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.